Most sponsors and CROs say their data isn't ready for AI. But agentic AI does not require a perfect data environment to begin delivering value. It can be deployed compliantly across siloed platforms, interpreting and reconciling differences in real time. In this 60-minute session, learn how AI agents deliver measurable value safely across clinical trials, reduce cognitive and operational burden, and enable teams to generate impact now while strengthening data foundations over time.

With 44,000+ oncology professionals in attendance, ASCO 2026 may have been the most consequential in recent years. From a standing ovation for pancreatic cancer to the first positive sarcoma trial in history, here's everything that mattered at Chicago's McCormick Place this week.

‍

Medable is a Palo Alto-based platform that has positioned itself as a leader specifically in decentralized clinical trials (DCT), eCOA, and — most recently — agentic AI. It has been deployed in nearly 400 trials across 70 countries and 120 languages, serving more than one million patients globally, and has been recognized as a Leader in eCOA by Everest Group.

‍